LRRK2 and Parkinson disease: We previously analyzed 235 urine samples from two independent cross-sectional cohorts (Columbia and LCC), including two types of controls, healthy individuals, and LRRK2 G2019S carriers not manifesting the disease, and PD patients with and without the LRRK2 G2019S mutation, quantifying 2,365 urinary proteins in total.25